Electric pulses in the spine may ease diabetic nerve pain

NCT ID NCT03228420

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial compares a spinal cord stimulation device (HF10 therapy) plus standard medical care against standard care alone for people with long-term, hard-to-treat leg pain caused by diabetic neuropathy. About 430 adults with stable pain levels and no major neurological changes are being randomly assigned to one of the two groups. The main goal is to see if more people in the stimulation group achieve at least a 50% reduction in pain without developing new nerve problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a device that delivers 10 kHz spinal cord stimulation (HF10 therapy)
What this could lead to
If successful, this could offer a new, non-drug option for people with painful diabetic neuropathy who do not get enough relief from standard treatments.
What could go wrong
This is a post-market study, so the device is already approved, but it may not work for everyone and carries surgical risks like infection or lead migration.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Pain Management

    Greenfield, Wisconsin, 53221, United States

  • Coastal Orthopedics

    Bradenton, Florida, 34209, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Georgia Pain Care

    Stockbridge, Georgia, 30281, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.